E-Learning

Nasdaq beats Q1 profit estimates on market volatility, strong product demand

(Reuters) -Nasdaq beat first-quarter profit expectations on Thursday as the exchange operator benefited from higher market volatility and strong demand for its fintech and solutions products, sending its shares up 1% before the bell. To diversify its revenue streams, the company has been expanding outside its market-sensitive core activities of trading and listing to products that help financial institutions navigate compliance requirements and safeguard against financial crimes. With markets remaining volatile in the first quarter amid economic uncertainty and the trade dispute between the United States and China, companies have been spending on products that help safeguard them from market volatility.

Read more

Apogee (NASDAQ:APOG) Exceeds Q1 Expectations, Full-Year Sales Guidance is Optimistic

Architectural products company Apogee (NASDAQ:APOG) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 4.5% year on year to $345.7 million. The company’s full-year revenue guidance of $1.4 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $0.89 per share was 2.3% above analysts’ consensus estimates.

Read more

S&P 500, Nasdaq inch higher on tech boost, earnings weigh on Dow

Wall Street's main indexes were mixed on Thursday, with the S&P 500 and the Nasdaq rising, as investors assessed a slew of mixed corporate results and monitored developments in U.S.-China trade war. The White House on Wednesday indicated that it was open to reducing sweeping tariffs on China, and President Donald Trump stepped back from his attacks on Federal Reserve Chairman Jerome Powell, sending stock indexes higher. But the optimism faded when Treasury Secretary Scott Bessent said a move to reduce levies would not come unilaterally, while China said in response that the U.S. should lift all unilateral tariff measures against China if it "truly" wanted to solve the trade issue.

Read more

Dow warns of earnings pressure due to tariff uncertainty

(Reuters) -Chemicals firm Dow Inc said on Thursday that it expects extended pressure on earnings as uncertainty from U.S. President Donald Trump's erratic trade policies adds to macroeconomic volatility. Along with other chemicals firms, Dow has been struggling with higher feedstock and energy costs as well as weak demand and prices for its products, especially in markets such as Europe. "Our industry is in one of the most protracted downcycles in decades," CEO Jim Fitterling said in a post-earnings call.

Read more

West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars

Healthcare products company West Pharmaceutical Services (NYSE:WST) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $698 million. The company’s full-year revenue guidance of $2.96 billion at the midpoint came in 2% above analysts’ estimates. Its non-GAAP profit of $1.45 per share was 18.1% above analysts’ consensus estimates.

Read more